While there is no easy solution to the current addiction problem, companies including the aerospace manufacturer are spearheading their own initiatives to combat the issue.
By continually reviewing prescription benefit policies and adapting them to current clinical information, employees are limited to their first exposure to addictive painkillers.
The insurer’s 25% reduction in painkiller scripts nearly a year ahead of schedule sets new tone for managing national epidemic, catches large brokerage’s attention.
